A U.S. Food and Drug Administration (FDA) advisory committee recently determined that phenylephrine, an ingredient commonly used to treat sinus and nasal congestion, is ineffective in treating these symptoms. This was apparent from research for years, yet large...
News
Latest News
Rubio Habla en La Poderosa
El senador estadounidense Marco Rubio (R-FL) habló con César Grajales de La Poderosa 670 AM en El Panorama Político, sobre la crisis fronteriza, sobre cómo los hispanoamericanos se ven afectados con la realidad del país, sobre los cargos contra el senador Bob Menéndez...
Rubio, Colleagues Reintroduce Bill to Protect Rights of Pregnant Students
Pregnant students are sometimes discriminated against by their schools, either intentionally or unintentionally and there is a concerning lack of awareness about the resources and rights available to them. Due to a lack of services and discrimination, these women may...
Rubio, Colleagues Reintroduce Intelligence Community Workforce Agility Protection Act
Currently, intelligence community civilians are subject to certain tax penalties for job-related relocation requirements, but active-duty military servicemembers are not subjected to the same penalties. These tax benefits, including the ability to deduct moving...
Rubio Delivers Remarks at Senate Intelligence Hearing
Vice Chairman of the Senate Select Committee on Intelligence Marco Rubio (R-FL) delivered opening remarks and questioned witnesses at a hearing on countering China’s influence in the United States. Watch Rubio’s opening remarks here as well as Part I and Part II of...
Rubio-led Resolution to Raise Awareness for Spinal Cord Injuries Passes Senate
Approximately 302,000 Americans live with spinal cord injuries. To help these people achieve a better quality of life, there is a need to increase education and invest in research. U.S. Senators Marco Rubio (R-FL) and Tammy Baldwin (D-WI) successfully led a bipartisan...
Rubio, Colleagues Introduce Legislation To Protect Intellectual Property Rights Of Vaccine Manufacturers
Washington, D.C. — U.S. Senators Marco Rubio (R-FL) and Marsha Blackburn (R-TN) introduced the No Free TRIPS Act. The bill would prevent the Biden Administration from interfering with the intellectual property rights of vaccine manufacturers through Trade-Related Aspects of Intellectual Property Rights (TRIPS) waivers.
“American companies worked at lightning speed to develop safe and effective COVID-19 vaccines,” Rubio said. “A TRIPS waiver would strip incentives for American drug manufacturers to step up when we need them to. This bill would protect the intellectual property of American companies and ensure that neither the Chinese Communist Party nor the Kremlin can claim American vaccines as their own.”
“President Trump’s Operation Warp Speed proved the life-saving capabilities of the private sector, but for some reason the Democrats are on a mission to stop this innovation in its tracks,” Blackburn said. “I am leading the charge to stop Joe Biden’s plan to waive the intellectual property rights of vaccine manufacturers. Without the power of free market innovation, we will lose any chance we have at successfully managing another global public health crisis.”
Senators Thom Tillis (R-NC), Tommy Tuberville (R-AL), Kevin Cramer (R-ND), Bill Hagerty (R-TN), Cynthia Lummis (R-WY), and Mike Lee (R-UT) are also original cosponsors.
Specifically, the No Free TRIPS Act would:
- Protect intellectual property of American vaccine manufacturers
- Encourage American innovation and production
- Ensure countries such as China or Russia are unable to claim American vaccines as their own